Condition 1: Neonatal hearing impairment. Condition 2: Iron deficiency anemia. Sensorineural hearing loss, unspecified anaemia
Conditions
Interventions
infants with Feritin concentrations corresponding to aforementioned definition of Latent Iron Deficiency, will be administered with 1 mg/kg iron drops (ferrous sulfate) from the start of the third wee
Treatment - Drugs
Sponsors
Maternal, Fetal & Neonatal Research Center, Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
14 Days to 30 Days
Inclusion criteria
Inclusion criteria: Inclusion criteria: Neonates with gestational ages>35 weeks and weight over 2,500 grshowing at least one of the risk factors for in utero Latent Iron Deficiency including maternal diabetes, maternal gestational hypertension, intrauterine growth restriction, and Serum Feritin levels between 11-75 ng/mL. Exclusion criteria: Neonates with craniofacial anomalies, chromosome abnormalities, hemolytic diseases, history of infectious disease in the third trimester, clinical evidence of chorioamnionitis, 5-minute Apgar scores<5, evidence of TORCH infections, clinical or laboratory diagnosed sepsis, history of hospitalization in the NICU due to any medical issue.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Neonatal hearing assessment. Timepoint: at birth and one month later. Method of measurement: ABR test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Elaheh Amini
Maternal Fetal and Neonatal Research Center
Outcome results
None listed